Good results from the study....anything to cure or stop the return of breast cancer is good news...BD
The drug anastrozole reduced the risk of breast cancer recurrence among postmenopausal women who took it for three years following treatment with tamoxifen.
A previous clinical trial showed that breast cancer patients who were still disease-free after taking tamoxifen for five years had their risk of recurrence further reduced if they received five additional years of treatment with the drug letrozole. Both anastrozole and letrozole are in the same class of drugs, known as aromatase inhibitors.
0 comments :
Post a Comment